Background: Venous thromboembolism (VTE) prophylaxis remains underutilized,
particularly in cancer patients. We explored clinical predictors of prophylaxis in hospitalized …

Cancer patients are at higher risk for venous thromboembolism (VTE). Anticoagulants, when
used for prophylaxis, had successfully reduced the incidence of VTE in high risk patients …

Purpose Venous thromboembolism (VTE) is an increasingly frequent complication of cancer
and its treatments, and is associated with worsened mortality and morbidity in patients with …

Hospitalized cancer patients are at high risk of venous thromboembolism (VTE). Despite
current recommendations in clinical guidelines, thromboprophylaxis with low molecular …

Cancer and its treatment are recognized risk factors for VTE. Compliance rate with published
VTE prophylaxis guidelines is low. Decision on when to offer prophylaxis for hospitalized …

Venous thromboembolism (VTE) is a common complication of cancer and chemotherapy.
We evaluated the baseline clinical characteristics, thromboprophylaxis patterns, frequency …

Patients with cancer are at increased risk for venous thromboembolism (VTE). Prolonged
medical hospitalization, extensive surgeries, central venous catheters (CVCs), and …

Venous thromboembolism (VTE) is a frequent complication of cancer and cancer-directed
therapy that leads to increased morbidity and mortality [1, 2]. Validated clinical scoring …

This is a literature review of the frequency of venous thromboembolism in hospitalized
patients with cancer and of the available evidence supporting the use of …

Purpose: Despite evidence-based recommendations existing for the prevention of venous
thromboembolism (VTE) in cancer patients, prophylaxis is often underused and …